INS and diabetes mellitus: Together, our results suggest that rather than changing the insulin concentration or altering the chemistry of the peptide, simply modulating the valency and geometry of insulin nanoclusters can control IR-mediated responses and may provide a starting point for the development of new drugs for the treatment of diabetes.